Provenance and documented origin
Who created the records, where they came from and how their history can be checked.
DATAQUIRE / LIFE SCIENCES
Better biological AI needs better evidence.
We help research organizations assess and license rights-cleared experimental datasets for scientific AI and pharmaceutical research.
DataQuire acts as an advisor and licensing intermediary. No public inventory or raw research data is exposed by this page.
- Origin
Source, method and version
- Context
Conditions, controls and replicates
- Observation
Results, corrections and limitations
- Permission
Owner-approved scope and access
Conceptual structure. Not a dataset or available inventory.
Why evidence matters
A result is only part of the record.
Biological AI needs contextualized experimental observations alongside published claims and molecular designs. Conditions, failed attempts, corrective steps, replicates, annotations and controls help explain a measured outcome.
Provenance makes that context traceable. Together, these details can affect whether a dataset is useful for a particular scientific task.
Scientific usefulness and buyer willingness to pay must be assessed separately. Scarce records are not automatically valuable.
Potentially licensable assets
The work behind the finding.
Illustrative categories for assessment. These are not owned inventory or a statement of available datasets.
Preclinical assay and dose-response records
Concentrations, methods, controls and measured responses kept together.
High-content microscopy and research imaging
Research images with acquisition conditions, annotations and experimental context.
Instrument output and laboratory measurement histories
Raw measurements linked to instrument settings, calibration and run history.
Screening campaigns, including informative negative results
Tested conditions and documented failures that help explain what did not work.
Preclinical experimental protocols, controls and outcomes
The method as performed, its comparators and the observations it produced.
Laboratory process records and documented corrections
Deviations, corrective steps and the evidence behind a changed procedure.
Research-origin non-patient datasets
Research records with verifiable provenance and a defined, permissible use.
Possible sources include LIMS, electronic lab notebooks (ELNs), instrument archives and research data repositories. These are source-system examples, not claims of access to particular installations or laboratories.
Evidence and rights
What makes an asset commercially usable.
Holding a file does not prove the right to license it.
Experimental context, controls and outcomes
Methods, conditions, replicates and annotations that make observations interpretable.
Completeness and known limitations
Coverage, missing records, quality checks and limits on what the evidence supports.
Ownership and third-party agreements
Who can authorize a license, including institutional, collaborator and sponsor obligations.
Permitted uses, confidentiality and restrictions
The allowed purpose, protected material and contractual boundaries on reuse.
Confirmed buyer use-case and authorized access pathway
A specific research need, a suitable license scope and owner-approved review.
Records remain in owner custody. Contractual permission and scientific quality review precede buyer-facing disclosure. Owners give specific authorization before access or transfer.
Two starting points
An owner. A research need.
A defined agreement.
DataQuire is an AI-native broker of proprietary operational and scientific datasets. We assess commercial suitability, coordinate agreed diligence and match owners with legitimate AI and R&D buyers. We are not the principal buyer or owner of licensed records.
For owners
Assess what you can license.
- Describe your records without uploading research files.
- DataQuire screens rights, scientific usefulness and buyer demand.
- You approve any confidential preview before it is shared.
- The parties negotiate a license defining permissible use.
- Payment follows the executed agreement if a deal closes.
For buyers
Start with the research task.
- Describe your intended model or research use, desired modalities, provenance needs and license restrictions.
- DataQuire searches for potential owners whose records could fit.
- Qualified matches proceed to consented review and negotiation.
Availability and timing depend on fit, permission and agreed terms.
Request scientific dataDo not submit patient-level data or raw protected health information (PHI) through public forms.
Healthcare records follow a separate review. Where law and the parties' roles require one, an applicable business associate agreement (BAA) and specialist review must be in place before access. An NDA or pseudonymization alone is not sufficient.
Institutional permissions, grant conditions, consent restrictions, publication agreements, ownership, confidentiality, clinical privacy requirements and export controls may affect whether a transaction can proceed.
Begin with a description of the records and their restrictions. Any later review or transfer requires an agreed, authorized pathway.
Research perspective
More designs.
Evidence still matters.
AI could increase the number of proposed drug candidates while validation and development remain constrained.
Our reading: trustworthy experimental evidence could become more important as proposed candidates multiply. This is a perspective, not proof of current dataset demand or DataQuire traction.
Start with the scope
Describe the records.
Define the next step.
Owners approve sharing and licenses. A description starts the assessment; it does not authorize access or commit anyone to a deal.